Dose Optimization using the Gene Therapy Virtual Twin Platform Blog Post
This blog explains how using the Gene Therapy Virtual Twin™ Platform can help optimize dosing for patients.
Be Honest, Be Reliable, Be Human: Insights from a Global Drug Development Expert Blog Post
One of the most exciting things about working in the pharmaceutical industry is the ability to meet and work with colleagues all over the world. In particular, China is one…
Certara Announces Pricing of its Upsized Initial Public Offering Blog Post
PRINCETON, NJ.— December 10, 2020 – Certara, Inc. (“Certara”), a global leader in biosimulation, today announced the pricing of its upsized initial public offering of 29,055,000 shares of its common…
Certara’s Phoenix software supports training of the next generation of the pharmacometricians in China Blog Post
The Pharmacy department of the Shanghai Chest Hospital is dedicated to developing and applying model-informed precision dosing (MIPD) and model-informed drug development (MIDD) models to optimize dosing for patients in…
Mechanistic model-informed discovery & development of bispecific antibodies for immuno-oncology: It takes 2 to tango Blog Post
More than 50 bispecific antibodies are in oncology clinical development with a large diversity in formats, directed at a range of immune and tumor targets. Bispecifics have demonstrated the potential…
Privacy Choices and Data Subject Rights Page
Privacy Choices and Data Subject RightsPrivacy Notice Page
Privacy Notice
Regulatory submissions and transactions with Health Canada Blog Post
By Robert Labriola We’ve seen recent trends and activity with regards to pharmaceutical regulatory submissions to Health Canada. Several questions and queries have come into our regulatory operations department, and…
Formatting Annotated Case Report Forms (aCRFs): Not Submitted Annotations and SDRG Blog Post
Simplify aCRFs with insights on “Not Submitted” annotations, reviewer’s guide tips, and define origin column details.
